Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
0.510
+0.050 (10.80%)
At close: Dec 5, 2025, 4:00 PM EST
0.510
-0.000 (-0.04%)
After-hours: Dec 5, 2025, 7:59 PM EST

Intensity Therapeutics Stock Forecast

INTS's stock price has decreased by -80.97% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 3 analysts with 12-month price forecasts for Intensity Therapeutics stock have an average target of 4.33, with a low estimate of 1.50 and a high estimate of 8.50. The average target predicts an increase of 749.02% from the current stock price of 0.51.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $1.50 $4.33 $3.00 $8.50
Change +194.12% +749.02% +488.24% +1566.7%
* Price targets were last updated on Aug 20, 2025.

Analyst Ratings

The average analyst rating for Intensity Therapeutics stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Jul '25Aug '25Sep '25Oct '25Nov '25Dec '25
Strong Buy 233332
Buy 111111
Hold 000000
Sell 000000
Strong Sell 000000
Total 344443

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Benchmark
Benchmark
Buy
Maintains
$4$1.5
Buy Maintains $4$1.5 +194.12% Aug 20, 2025
Brookline Capital
Brookline Capital
Strong Buy
Upgrades
$3
Strong Buy Upgrades $3 +488.24% Aug 12, 2025
Alliance Global Partners
Alliance Global Partners
Strong Buy
Initiates
$8.5
Strong Buy Initiates $8.5 +1,566.67% Jan 13, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$5
Strong Buy Reiterates $5 +880.39% Nov 21, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$5
Strong Buy Initiates $5 +880.39% Oct 31, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.35
from -1.17
EPS Next Year
-0.22
from -0.35
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
-------
Revenue Growth
-------
EPS
-1.77-2.32-2.22-1.38-1.17-0.35-0.22
EPS Growth
-------
Forward PE
-------
No. Analysts -----76
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027202820292030
High n/a n/a
Avg n/a n/a
Low n/a n/a

Revenue Growth

Revenue Growth 202520262027202820292030
High - -
Avg - -
Low - -

EPS Forecast

EPS 202520262027202820292030
High -0.35 -0.20
Avg -0.35 -0.22
Low -0.34 -0.25

EPS Growth

EPS Growth 202520262027202820292030
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.